Page 166 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

142 J. Charles Jennette, Ronald J. Falk and Adil. H. M. Gasim

[13] Jennette, J. C., Falk, R. J., Hu, P., et al. Pathogenesis of Anti-neutrophil Cytoplasmic
Autoantibody Associated Small Vessel Vasculitis. Annu. Rev. Pathol. Mech. Dis. 2013;
8: 139-160.

[14] Lionaki, S., Blyth, E. R., Hogan, S. L., et al. Classification of antineutrophil
cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic
autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and
prognosis. Arthritis Rheum. 2012; 64:3452-3462.

[15] Lanham, J. G., Churg, J. Churg-Strauss syndrome. In: Churg, J., ed. Systemic
Vasculitides. New York, Igaku-Shoin, 1991:101-120.

[16] Cohen Tervaert, J. W., Damoiseaux, J. Antineutrophil cytoplasmic autoantibodies: how
are they detected and what is their use for diagnosis, classification and follow-up? Clin.
Rev. Allergy Immunol. 2012; 43:211-219.

[17] Sinico, R. A., Di Toma, L., Maggiore, U., et al. Renal involvement in Churg-Strauss
syndrome. Am. J. Kidney Dis. 2006; 47:770-779.

[18] Lombard, C. M., Colby, T. V., Elliott, C. G. Surgical pathology of the lung in anti-
basement membrane antibody-associated Goodpasture?s syndrome. Hum. Pathol. 1989;
20:445-451.

[19] Levy, J. B., Hammad, T., Coulthart, A., et al. Clinical features and outcome of patients
with both ANCA and anti-GBM antibodies. Kidney Int. 2004; 66:1535-1540.

[20] Tedeschi, A., Barate, C., Minola, E., et al. Cryoglobulinemia. Blood Rev. 2007; 21:183-
200.

[21] Lauletta, G., Russi, S., Conteduca, V., et al. Hepatitis C virus infection and mixed
cryoglobulinemia. Clin. Dev. Immunol. 2012; 2012:502156.

[22] Suzuki, H., Kiryluk, K., Novak, J., et al. The pathophysiology of IgA nephropathy. J.
Am. Soc. Nephrol. 2011; 22:1795-1803.

[23] Suzuki, H., Fan, R., Zhang, Z., et al. Aberrantly glycosylated IgA1 in IgA nephropathy
patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest.
2009; 119:1668-1677.

[24] Davis, M. D., Brewer, J. D. Urticarial vasculitis and hypocomplementemic urticarial
vasculitis syndrome. Immunol. Allergy Clin. North Am. 2004; 24:183-213.

[25] Kallenberg, C. G. Anti-C1q autoantibodies. Autoimmun. Rev. 2008; 7:612-615.
[26] Jara, L. J., Navarro, C., Medina, G., et al. Hypocomplementemic urticarial vasculitis

syndrome. Curr. Rheumatol. Rep. 2009; 11:410-415.
[27] Saadoun, D., Asli, B., Wechsler, B., et al. Long-term outcome of arterial lesions in

Behçet disease: a series of 101 patients. Medicine 2012; 91:18-24.
[28] Calamia, K. T., Schirmer, M., Melikoglu, M. Major vessel involvement in Behcet

disease. Curr. Opin. Rheumatol. 2005; 17:1-8.
[29] Kalkan, G., Karadag, A. S., Astarci, H. M., et al. A histopathological approach: when

papulopustular lesions should be in the diagnostic criteria of Behçet's disease? J. Eur.
Acad. Dermatol. Venereol. 2009; 23:1056-1060.
[30] Gaubitz, M., Lübben, B., Seidel, M., et al. Cogan's syndrome: organ-specific
autoimmune disease or systemic vasculitis? A report of two cases and review of the
literature. Clin. Exp. Rheumatol. 2001; 19:463-469.
[31] Gasparovic, H., Djuric, Z., Bosnic, D., et al. Aortic root vasculitis associated with
Cogan's syndrome. Ann. Thorac. Surg. 2011; 92:340-341.

Complimentary Contributor Copy